Table 3 Clinical and AMI-treatment-related data (1) in patients with and without early depressive symptoms 5 days after AMI; (2) in patients with and without depression 6 months after AMI; and 3) in depressive patients with and without comorbid PTSD 6 months after AMI.

Anthropometry

Height (cm)

Median (Range)

176 (152 − 19)

175 (155–196)

.52^d

175 (155–196)

176 (152–191)

.27^d

174 (155–185)

175,5 (162–196)

.16^d

Weight (kg)

Median (Range)

86 (54–119)

85 (53–132)

.96^d

85 (53–132)

85 (54–119)

.99^d

87 (53–132)

84,5 (65–128)

.96^d

Cardiac status at time of admission

STEMI

n (%)

35 (43%)

47 (47%)

> .99^a

42 (51%)

40 (49%)

.86^a

25 (60%)

17 (40%)

.20^a

NSTEMI

n (%)

20 (43%)

27 (57%)

25 (53%)

22 (47%)

19 (76%)

6 (24%)

Killip mortality risk stratification

Killip class I

n (%)

41 (41%)

60 (59%)

χ² = 4.221;

p = .24^{c, e}

52 (51%)

49 (49%)

χ² = 2.762;

p = .43^{c, e}

35 (67%)

17 (33%)

χ² = 1.096,;

p = .78^{c, e}

Killip class II

n (%)

5 (63%)

3 (38%)

5 (63%)

3 (38%)

3 (60%)

2 (40%)

Killip class III

n (%)

3 (50%)

3 (50%)

3 (50%)

3 (50%)

2 (67%)

1 (33%)

Killip class IV

n (%)

2 (100%)

0 (0%)

2 (100%)

0 (0%)

2 (100%)

0 (0%)

Abnormal level of troponin T

n (%)

55 (43%)

74 (57%)

-

67 (52%)

62 (48%)

-

44 (66%)

23 (34%)

-

Cardiogenic shock

n (%)

0 (-)

0 (-)

-

0 (-)

0 (-)

-

0 (-)

0 (-)

-

AMI-related resuscitation

n (%)

3 (75%)

1 (25%)

.31^a

3 (75%)

1 (25%)

.62^a

3 (100%)

0 (0%)

.55^a

ECG: Frequency (beats/min)

Median (Range)

70 (46–104)

72 (52–108)

.53^d

70 (46–106)

73,5 (52–108)

.57^d

70 (46–106)

70 (50–104)

.86^d

ECG: Atrial fibrillation

n (%)

5 (62%)

3 (38%)

.28^a

6 (75%)

2 (25%)

.27^a

3 (50%)

3 (50%)

.41^a

PCI-related parameters

 TIMI flow before PCI

  0

n (%)

8 (62%)

5 (38%)

χ² = 1.415;

p = .70^{c, e}

7 (54%)

6 (46%)

χ² = 5.739;

p = .057^{c, e}

3 (43%)

4 (57%)

χ² = 2.100,;

p = .55^{c, e}

  0-I

n (%)

50 (55%)

41 (45%)

48 (53%)

43 (47%)

32 (67%)

16 (33%)

  II

n (%)

12 (60%)

8 (40%)

8 (40%)

12 (60%)

6 (75%)

2 (25%)

  III

n (%)

4 (80%)

1 (20%)

4 (80%)

1 (20%)

3 (75%)

1 (25%)

 TIMI flow after PCI

  0

n (%)

0 (-)

0 (-)

χ² = 5.739; p = .057^{c, e}

0 (-)

0 (-)

χ² = 1.601;

p = .45^{c, e}

0 (-)

0 (-)

χ² = 3.365;

p = .76^{c, e}

  0-I

n (%)

4 (80%)

1 (20%)

1 (20%)

4 (80%)

1 (100%)

0 (0%)

  II

n (%)

2 (22%)

7 (78%)

8 (89%)

1 (11%)

5 (63%)

3 (37%)

  III

n (%)

68 (59%)

47 (41%)

58 (50%)

57 (50%)

38 (66%)

20 (34%)

Multivessel PCI

n (%)

11 (41%)

16 (59%)

.52^a

16 (59%)

11 (41%)

χ² = 1.601,

p = .45^c

12 (75%)

4 (25%)

.55^a

Max. stent length in the target vessel (mm)

Median (Range)

28 (12–126)

26 (10–82)

.29^d

28 (13–126)

25 (10–82)

.35^d

28 (13–126)

28 (15–72)

.95^d

Max. stent diameter in the target vessel (mm)

Median (Range)

300 (250–400)

300 (100–400)

> .99^d

300 (250–400)

300 (100–400)

.56^d

300 (250–400)

300 (250–400)

.50^d

In-hospital outcome

Death

n (%)

0 (-)

0 (-)

-

0 (-)

0 (-)

-

0 (-)

0 (-)

-

Stroke

n (%)

0 (-)

0 (-)

-

0 (-)

0 (-)

-

0 (-)

0 (-)

-

Major bleeding

n (%)

0 (-)

0 (-)

-

0 (-)

0 (-)

-

0 (-)

0 (-)

-

Reinfarction

n (%)

0 (0%)

2 (100%)

.51^a

0 (0%)

2 (100%)

χ² = 2.812,

p = .25^c

0 (-)

0 (-)

-

Left-ventricular ejection fraction (%)

Median (Range)

55 (15–70)

50 (30–70)

.30^d

54,5 (15–70)

50 (30–70)

.45^d

53 (15–70)

54,5 (15–70)

.47^d

Cardiac risk factors

Known coronary artery disease

n (%)

10 (45%)

12 (55%)

> .99^a

16 (73%)

6 (27%)

.06^a

11 (69%)

5 (31%)

> .99^a

Nicotine abuse

n (%)

28 (47%)

31 (53%)

.31^a

29 (49%)

30 (51%)

.60^a

20 (69%)

9 (31%)

.80^a

Peripheral arterial occlusive disease

n (%)

2 (50%)

2 (50%)

> .99^a

3 (75%)

1 (25%)

.62^a

3 (100%)

0 (0%)

0.55^a

IDDM

n (%)

1 (50%)

1 (50%)

> .99^a

2 (100%)

0 (0%)

.50^a

1 (50%)

1 (50%)

> .99^a

NIDDM

n (%)

6 (32%)

13 (68%)

.33^a

12 (63%)

7 (37%)

.33^a

10 (83%)

2 (17%)

.20^a

Hypertension

n (%)

48 (42%)

67 (58%)

.58^a

58 (50%)

57 (50%)

.40^a

36 (62%)

22 (38%)

.15^a

Hyperlipidemia

n (%)

34 (49%)

35 (51%)

.15^a

41 (59%)

28 (41%)

.15^a

27 (66%)

14 (34%)

> .99^a

Positive family history

n (%)

12 (50%)

12 (50%)

.64^a

12 (50%)

12 (50%)

> .99^a

7 (58%)

5 (42%)

.48^a

History of myocardial infarction

n (%)

7 (50%)

7 (50%)

.58^a

11 (79%)

3 (21%)

0.047^a

9 (82%)

2 (18%)

.48^a

Severe liver disease

n (%)

2 (67%)

1 (33%)

.58^a

1 (33%)

2 (67%)

.61^a

0 (0%)

1 (100%)

.34^a

History of TIA or Stroke

n (%)

2 (50%)

2 (50%)

> .99^a

3 (75%)

1 (25%)

.62^a

1 (33%)

2 (67%)

.26^a